Accord is one of the fastest growing generic companies in the world and has one of the most extensive sales, marketing and distribution network in Europe. Headquartered from UK, Accord now supplies products in over 30 European countries. Sales growth in the last 12 months was over 100% bringing revenues of $115 million and significant double digit growth is anticipated in the coming year. Accord has a particular strength in the hospital or institutional setting and last year sales associated with this segment grew 197%.
Accord Europe currently has over 7000 product approvals across 183 INNs and this number is expected to grow significantly over the next few years allowing Accord to compete with some of the biggest portfolios in the industry.
Accord has also invested significantly in an increasing commercial infrastructure across the region and manages its own warehousing, logistics, regulatory, quality, intellectual property and sales and marketing requirements within region. A key value add for Accord Europe is its own warehousing and packaging complex located near Cambridge UK, which facilitates high degree of supply chain flexibility. Accord’s dedicated market sales-forces reach over 97% of the patient population of the EU.